reports
Nokia Corp: 1 director
A director at Nokia Corp sold 33,500 shares at 6.994EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...
Changes in Nokia Corporation's own shares
Changes in Nokia Corporation's own shares Nokia CorporationStock Exchange Release18 March 2026 at 16:30 EETChanges in Nokia Corporation's own shares Espoo, Finland – A total of 1 222 899 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia's equity-based incentive plans in accordance with the rules of the plans. The transfer is based on the resolution of the Board of Directors to issue shares held by the company to settle its commitments to participants of the incentive plans as announced on 2 October 2025. The number of own shares...
Muutokset Nokia Oyj:n omien osakkeiden omistuksessa
Muutokset Nokia Oyj:n omien osakkeiden omistuksessa Nokia OyjPörssitiedote18.3.2026 klo 16.30Muutokset Nokia Oyj:n omien osakkeiden omistuksessa Espoo – Nokia on tänään luovuttanut 1 222 899 yhtiön hallussa ollutta Nokian osaketta (NOKIA) vastikkeetta suorituksena Nokian osakepohjaisiin kannustinohjelmiin osallistuneille henkilöille ohjelmien ehtojen mukaisesti. Osakkeiden luovutus perustuu 2.10.2025 julkistettuun hallituksen päätökseen yhtiön hallussa olevien osakkeiden antamisesta kannustinohjelmien mukaisten sitoumusten täyttämiseksi. Nokia Oyj:n hallussa olevien omien osakkeiden lukum...
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designat...
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease Paris, March 18, 2026. The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to venglustat, a novel, investigational oral glucosylceramide synthase inhibitor (GCSi), for the treatment of neurological manifestations of type 3 Gaucher disease (GD3), a rare lysosomal storage disorder. The designation is based on data from the LEAP2MONO phase 3 study (clin...
Communiqué de presse : Le venglustat de Sanofi a reçu la désignation d...
Communiqué de presse : Le venglustat de Sanofi a reçu la désignation de thérapie innovante aux États-Unis pour la maladie de Gaucher de type 3 Le venglustat de Sanofi a reçu la désignation de thérapie innovante aux États-Unis pour la maladie de Gaucher de type 3 Paris, le 18 mars 2026. La Food and Drug Administration (FDA) des États-Unis a accordé la désignation de thérapie innovante au venglustat, un nouvel inhibiteur expérimental de la glucosylcéramide synthase (GCSi) administré par voie orale, pour le traitement des manifestations neurologiques de la maladie de Gaucher de type 3 (MG...
Nokia brings PON-based out-of-band management to data centers to save ...
Nokia brings PON-based out-of-band management to data centers to save space, power and cost Press ReleaseNokia brings PON-based out-of-band management to data centers to save space, power and cost Out-of-band management (OOBM) provides a secure and always-on control path to monitor, manage and recover critical server infrastructure in data centers. Nokia Aurelis for Data Centers is a purpose-built solution for out-of-band management.Aurelis leverages Passive Optical Network (PON) fiber technology to significantly reduce the amount of active equipment, power and operational cost. Espoo, F...
Nokia launches suite of application‑optimized optical solutions for AI...
Nokia launches suite of application‑optimized optical solutions for AI-era networks Press ReleaseNokia launches suite of application‑optimized optical solutions for AI-era networks Nokia introduces a new suite of application-optimized coherent transport solutions enabling significant improvements in network efficiency and providing up to 70% lower total cost of ownership. Nokia launches a compact, in-line amplifier optimized for multi-fiber applications that enables network operators to deliver up to 40x more services in the same footprint.Nokia shares its vision for optical networking hig...
Moody's Ratings announces completion of a periodic review of ratings o...
Announcement of Periodic Review: Moody's Ratings announces completion of a periodic review of ratings of SAP SE. Global Credit Research- 13 Mar 2026. Frankfurt am Main, March 13, 2026-- Moody's Ratings has completed a periodic review of the ratings of SAP SE and other ratings that are associated with this issuer.
- Pierre FerraguÊ
Bible 4Q25 - Telecom Infrastructure: No capex growth in sight. Mobile ...
Today, we are publishing the Telecom Infrastructure section of our 30th Tech Infrastructure Quarterly Bible. The Tech Bible is a must-read for any tech investor, as it summarizes the quarterly earnings reports from the over 140 companies we track, providing an update on our key perspectives and convictions. Telecom capex was flat year-on-year in 4Q25 and operator guidance implies this trend will continue in 2026. The outlook for equipment vendors is in line with our expectations: mobile stable,...
Sanofi: Information concerning the total number of voting rights and s...
Sanofi: Information concerning the total number of voting rights and shares - February 2026 Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of €2,424,365,088Registered office : 46, avenue de la Grande Armée - 75017 Paris - FranceRegistered at the Paris Commercial and Companies Registry ...
Sanofi: Informations relatives au nombre de droits de vote et d'action...
Sanofi: Informations relatives au nombre de droits de vote et d'actions - FEVRIER 2026 Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers SanofiSociété anonyme au capital de 2 424 365 088 euros Siège social : 46, avenue de la Grande Armée - 75017 Paris395 030 844 R.C.S. Paris Date Nombre d’actions composant le capital Nombre réel de droits de vote (déduction faite des actions auto-détenues)Nombre théorique de droits de vote (y compris actio...
Nokia Corporation - Managers' transactions (Sahgal)
Nokia Corporation - Managers' transactions (Sahgal) Nokia CorporationManagers’ transactions10 March 2026 at 16:30 EETNokia Corporation - Managers' transactions (Sahgal) Transaction notification under Article 19 of EU Market Abuse Regulation.____________________________________________Person subject to the notification requirementName: Sahgal, Raghav Position: Other senior manager Issuer: Nokia CorporationLEI: 549300A0JPRWG1KI7U06Notification type: INITIAL NOTIFICATIONReference number: 146612/5/4____________________________________________Transaction date: 2026-03-10Trading venue: XLOMInst...
Nokia Oyj - Johtohenkilöiden liiketoimet (Sahgal)
Nokia Oyj - Johtohenkilöiden liiketoimet (Sahgal) Nokia OyjJohtohenkilöiden liiketoimet10.3.2026 klo 16.30Nokia Oyj - Johtohenkilöiden liiketoimet (Sahgal) Markkinoiden väärinkäyttöasetuksen 19. artiklan mukainen ilmoitus liiketoimesta.____________________________________________IlmoitusvelvollinenNimi: Sahgal, RaghavAsema: Muu ylin johto Liikkeeseenlaskija: Nokia CorporationLEI: 549300A0JPRWG1KI7U06Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 146612/5/4____________________________________________Liiketoimen päivämäärä: 2026-03-10Kauppapaikka: XLOMInstrumenttityyppi: OSAKEISIN: FI...
- ABGSC Telecom Equipment Research
- Simon Granath
- Dominic Rose
- Naresh Chouhan
Intron Health - AI Impact on Pharma - Thematic (20pgs) - Winners/Loser...
Our Big Pharma AI thesis is the result of ~25 interviews with industry execs & >100hrs of research. We show ~10% of OPEX could be saved by AI within a few years & conclude the recent sector rally is wholly justified & could run further. We assess the winners & losers from AI adoption and discuss in detail some of the short, mid & long-term consequences. We evaluate the various AI use cases and quantify the potential benefit they may have. We break down SG&A & R&D activities & show where AI is im...
Notification under Chapter 9, Section 10 of the Finnish Securities Mar...
Notification under Chapter 9, Section 10 of the Finnish Securities Market Act: voting rights of FMR LLC in Nokia Corporation exceeded 5% Nokia CorporationStock Exchange Release6 March 2026 at 22:00 EETNotification under Chapter 9, Section 10 of the Finnish Securities Market Act: voting rights of FMR LLC in Nokia Corporation exceeded 5% Notification under Chapter 9, Section 10 of the Finnish Securities Market Act: voting rights of FMR LLC in Nokia Corporation exceeded 5% According to a notification received under Chapter 9, Section 5 of the Finnish Securities Market Act (FSMA) by Nokia Cor...
Arvopaperimarkkinalain 9 luvun 10 §:n mukainen ilmoitus: FMR LLC:n ään...
Arvopaperimarkkinalain 9 luvun 10 §:n mukainen ilmoitus: FMR LLC:n ääniosuus Nokia Oyj:stä ylitti 5 % Nokia OyjPörssitiedote6.3.2026 klo 22.00Arvopaperimarkkinalain 9 luvun 10 §:n mukainen ilmoitus: FMR LLC:n ääniosuus Nokia Oyj:stä ylitti 5 % Arvopaperimarkkinalain 9 luvun 10 §:n mukainen ilmoitus: FMR LLC:n ääniosuus Nokia Oyj:stä ylitti 5 % Nokia Oyj on vastaanottanut Arvopaperimarkkinalain 9 luvun 5 §:n mukaisen ilmoituksen, jonka mukaan FMR LLC:n välillinen ääniosuus Nokia Oyj:n äänioikeuksien kokonaismäärästä on 5.3.2026 ylittänyt 5 prosentin rajan. Nokia Oyj:n osakk...
- ABGSC Telecom Equipment Research
- Simon Granath
- Research Department
IBERIAN DAILY 06 MARCH (ANÁLISIS BANCO SABADELL)
NEWS SUMMARY: BBVA, NEINOR HOMES, REPSOL. Volatility reigns European stock markets were back in the red, with oil prices continuing to climb in a session marked by the growing tensions between Iran and the US/Israel. In the STOXX 600, Technology and Media led the advances, with Household Goods and Basic Materials showing the worst relative performance. On the macro side, in the euro zone January’s retail sales rose more than expected (YoY). The ECB meeting minutes welcomed the solid inflation ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.